Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02987829
Title A Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients
Recruitment Completed
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Tracon Pharmaceuticals Inc.
Indications

prostate adenocarcinoma

Therapies

TRC253

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.